Lukin Medical Completes RMB 35 Million Series A Financing

Shanghai-based Lukin Medical completes RMB 35 million ($4.9 million) series A financing led by Hermed Capital for new ultra-minimally invasive products development, production facility, and product promotion.

Lukin Medical received China’s National Medical Products Administration (NMPA) approval in 2020 for MICROS with 20 models, meeting the surgical needs of puncture, grasping, segmentation, coagulation, and separation, and is suitable for all procedures on the endoscopic surgical platform.

Lukin Medical provides medical device customisation services based on doctors’ clinical practice and personalised requirements, and has established cooperative relationships with dozens of tier 3A hospitals in China.